Filing Details

Accession Number:
0001729637-23-000006
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2023-06-26 10:27:04
Reporting Period:
2023-04-25
Accepted Time:
2023-06-26 10:27:04
Original Submission Date:
2023-04-27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1018735 Nymox Pharmaceutical Corp NYMX In Vitro & In Vivo Diagnostic Substances (2835) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1651844 George James Robinson 10 East Lee Street
Suite 2705
Baltimore MD 21202
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-04-25 40,000 $0.45 4,742,065 No 4 P Direct
Common Stock Acquisiton 2023-04-27 40,000 $0.47 4,782,065 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct